West Pharmaceutical Services Inc (WST) Sec Form 8K
West Pharmaceutical Services Inc (NYSE: WST) Sec Form 8K
21 articles, transcripts, and reports
West Pharmaceutical Services Inc (NYSE: WST) Sec Form 8K
West Pharmaceutical Services, Inc. (NYSE: WST) reported fourth-quarter 2025 financial results on Thursday that exceeded analyst expectations, supported by strong...
West Pharmaceutical Services Inc (NYSE: WST) Q4 2025 Earnings Conference
West Pharmaceutical Services Inc (NYSE: WST) Q4 2025 Earnings Release
West Pharmaceutical Services Inc (NYSE: WST) Q2 2025 Earnings Call dated Jul. 24, 2025 Corporate Participants: John Sweeney — Vice President – Investor Relations Eric…
West Pharmaceutical Services Inc (NYSE: WST) Q3 2025 Earnings Call dated Oct. 23, 2025 Corporate Participants: John Sweeney — Head of Investor Relations Eric M.…
West Pharmaceutical Services Inc (NYSE: WST) Q2 2022 Earnings Conference
West Pharmaceutical Services Inc (NYSE: WST) Q1 2022 Earnings Conference
West Pharmaceutical Services Inc (NYSE: WST) Q3 2021 Earnings Conference
West Pharmaceutical Services Inc (NYSE: WST) Q2 2021 Earnings Conference